$OKLO

DeWitte Jacob sold $4.1M of OKLO

DeWitte Jacob (Co-Founder, CEO) sold 60,000 shares of Oklo Inc. (OKLO) at $68.29 ($4.10M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DeWitte Jacob
Published Jun 2, 2026, 9:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OKLO
Neutral
medium confidence
Mentioned
$OKLO
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

The disclosure can affect short-term sentiment, but 10b5-1 reduces the likelihood of it being a new, information-driven signal.

02

Market read

A $4.1M insider sale was disclosed; traders may monitor for follow-on selling or changes in insider/holder behavior.

03

What to watch

The filing does not reveal motivations or whether other insiders/large holders changed positions; also, share price reaction may depend on whether the market was already expecting insider selling.

Relevance 6/10Novelty 7/10Timing: Filed after-hours/late day (2026-06-02 17:10 ET) disclosing a 2026-06-01 sale

Background

SEC Form 4 reports insider transactions for Oklo; the sale was executed under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$OKLONeutralMedium confidence
Context

Oklo co-founder/CEO DeWitte Jacob sold 60,000 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term price impact; could add mild overhang if market interprets as reduced conviction.

Evidence & confidence

The filing is a routine insider sale with 10b5-1 pre-arrangement, providing less surprise than unscheduled selling; however, size/value ($4.1M) can still influence sentiment.

Market effects

Minimal; this is company-specific insider liquidity/positioning rather than sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale was executed under a pre-arranged 10b5-1 plan, it may reflect scheduled diversification/liquidity needs rather than negative outlook.

Key entities

  • Oklo Inc.

    Subject of the Form 4 insider sale by its co-founder/CEO.

  • DeWitte Jacob

    Co-founder, CEO, officer/director/10% owner who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HNUCMed

A New Nuclear Rival Recently Filed to Go Public. Should Oklo Investors Be Worried?

Holtec Nuclear Corporation filed for an IPO on Nasdaq (ticker HNUC), generating $165M revenue and $17.8M net income in Q1 2024. Unlike Oklo (OKLO), Holtec has existing revenue and earnings, focusing on nuclear equipment, waste management, and SMR development. Holtec plans to use IPO proceeds for SMR programs and expansion. Oklo, a pre-commercial nuclear startup, has minimal revenue and significant losses, raising concerns for investors.

$CCJMedAI 8/10

AI Energy Demands Surge, Nuclear Power Seeks to Break the Deadlock

Nuclear energy sector is poised for long-term growth due to rising AI data center demand and government policies. Cameco (CCJ) benefits from uranium mining and reactor manufacturing. GE Vernova (GEV) is developing small modular reactors with a project scheduled for 2029. High-risk startups Oklo (OKLO) and NuScale Power (SMR) are seeking commercial agreements for future deployment.

MedAI 8/10

Oklo aims to turn nuclear waste into clean energy

Oklo Inc. plans to invest $1.68B to build a nuclear fuel recycling facility in Oak Ridge, converting used nuclear fuel into reusable materials. The company aims to address rising electricity demand and domestic HALEU supply shortages. Christina Leggett, director of fuel cycle technology, leads the project, leveraging pyroprocessing technology.

$OKLOMed

Oklo Climbs 12% As Supply Concerns Spark Rally In Advanced Nuclear Stocks

Oklo (OKLO) stock rose 12% to $44 on supply concerns amid U.S.-Canada trade tensions, adding $850M to its market cap. The company's Aurora reactors rely on advanced fuels, and recent political developments highlight risks tied to material access. Oklo has strong cash reserves ($3.01B) and operational milestones, like its Groves reactor reaching criticality. Analysts' price targets range from $14 to $130, with an average of $80.